| Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma AI Daud, K Loo, ML Pauli, R Sanchez-Rodriguez, PM Sandoval, ... The Journal of clinical investigation 126 (9), 3447-3452, 2016 | 530 | 2016 |
| Liver metastasis and treatment outcome with anti-PD-1 monoclonal antibody in patients with melanoma and NSCLC PC Tumeh, MD Hellmann, O Hamid, KK Tsai, KL Loo, MA Gubens, ... Cancer immunology research 5 (5), 417-424, 2017 | 442 | 2017 |
| Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy A Nosrati, KK Tsai, SM Goldinger, P Tumeh, B Grimes, K Loo, AP Algazi, ... British journal of cancer 116 (9), 1141-1147, 2017 | 140 | 2017 |
| Outcomes of melanoma in situ treated with Mohs micrographic surgery compared with wide local excision A Nosrati, JG Berliner, S Goel, J McGuire, V Morhenn, JR de Souza, ... JAMA dermatology 153 (5), 436-441, 2017 | 100 | 2017 |
| Sex disparities in melanoma outcomes: the role of biology A Nosrati, ML Wei Archives of biochemistry and biophysics 563, 42-50, 2014 | 77 | 2014 |
| Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy K Loo, KK Tsai, K Mahuron, J Liu, ML Pauli, PM Sandoval, A Nosrati, ... JCI insight 2 (14), 2017 | 75 | 2017 |
| Liver metastasis and treatment outcome with anti-PD-1 monoclonal antibody in patients with melanoma and NSCLC. Cancer Immunol. Res. 2017; 5: 417–424. doi: 10.1158/2326-6066 PC Tumeh, MD Hellmann, O Hamid, KK Tsai, KL Loo, MA Gubens, ... CIR-16-0325.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 64 | |
| Dual MEK/AKT inhibition with trametinib and GSK 2141795 does not yield clinical benefit in metastatic NRAS‐mutant and wild‐type melanoma AP Algazi, R Esteve‐Puig, A Nosrati, B Hinds, A Hobbs‐Muthukumar, ... Pigment cell & melanoma research 31 (1), 110-114, 2018 | 56 | 2018 |
| Dietary modifications in atopic dermatitis: patient-reported outcomes A Nosrati, L Afifi, MJ Danesh, K Lee, D Yan, K Beroukhim, R Ahn, W Liao Journal of Dermatological Treatment 28 (6), 523-538, 2017 | 56 | 2017 |
| All-cause mortality in patients with basal and squamous cell carcinoma: A systematic review and meta-analysis MR Wehner, WC Serrano, A Nosrati, PM Schoen, MM Chren, J Boscardin, ... Journal of the American Academy of Dermatology 78 (4), 663-672. e3, 2018 | 39 | 2018 |
| The role of technology in melanoma screening and diagnosis AT Young, NB Vora, J Cortez, A Tam, Y Yeniay, L Afifi, D Yan, A Nosrati, ... Pigment Cell & Melanoma Research 34 (2), 288-300, 2021 | 36 | 2021 |
| Diagnostic markers of serious bacterial infections in febrile infants younger than 90 days old A Nosrati, A Ben Tov, S Reif Pediatrics International 56 (1), 47-52, 2014 | 33 | 2014 |
| Outcomes and risk factors in patients with multiple primary melanomas A Nosrati, YY Wesley, J McGuire, A Griffin, JR de Souza, R Singh, E Linos, ... Journal of Investigative Dermatology 139 (1), 195-201, 2019 | 27 | 2019 |
| Skin cancer prevention messages on Facebook: Likes, shares, and comments A Nosrati, MA Pimentel, A Falzone, R Hegde, S Goel, MM Chren, R Eye, ... Journal of the American Academy of Dermatology 79 (3), 582-585. e1, 2018 | 22 | 2018 |
| Correlation between metastatic site and response to anti-Programmed Death-1 (PD-1) agents in melanoma. SM Goldinger, KK Tsai, P Tumeh, O Hamid, A Nosrati, K Loo, B Grimes, ... Journal of Clinical Oncology 34 (15_suppl), 9549-9549, 2016 | 18 | 2016 |
| A combination of non-ablative laser and hyaluronic acid injectable for postacne scars: a novel treatment protocol L Akerman, D Mimouni, A Nosrati, D Hilewitz, E Solomon-Cohen The Journal of Clinical and Aesthetic Dermatology 15 (3), 53, 2022 | 11 | 2022 |
| 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016 A Lundqvist, V van Hoef, X Zhang, E Wennerberg, J Lorent, K Witt, ... Journal for immunotherapy of cancer 4, 1-106, 2016 | 10 | 2016 |
| Does interval time between pulsed dye laser treatments for port-wine stains influence outcome? A systematic review and meta-analysis I Snast, M Lapidoth, R Kaftory, A Nosrati, E Hodak, D Mimouni, ... Lasers in Medical Science, 1-8, 2021 | 8 | 2021 |
| Treatment of bullous pemphigoid in people aged 80 years and older: a systematic review of the literature M Oren-Shabtai, N Kremer, M Lapidoth, E Sharon, L Atzmony, A Nosrati, ... Drugs & Aging 38, 125-136, 2021 | 7 | 2021 |
| Derivation and validation of a prediction scale for response to PD-1 monotherapy. A Nosrati, SM Goldinger, KK Tsai, K Loo, P Tumeh, O Hamid, AP Algazi, ... Journal of Clinical Oncology 34 (15_suppl), 9514-9514, 2016 | 3 | 2016 |
